Literature DB >> 15585836

CXCR4-tropic HIV-1 envelope glycoprotein functions as a viral chemokine in unstimulated primary CD4+ T lymphocytes.

Karl Balabanian1, Julie Harriague, Christine Décrion, Bernard Lagane, Spencer Shorte, Françoise Baleux, Jean-Louis Virelizier, Fernando Arenzana-Seisdedos, Lisa A Chakrabarti.   

Abstract

Interaction of HIV-1 envelope glycoprotein gp120 with the chemokine receptor CXCR4 triggers not only viral entry but also an array of signal transduction cascades. Whether gp120 induces an incomplete or aberrant set of signals, or whether it can function as a full CXCR4 agonist, remains unclear. We report that, in unstimulated human primary CD4(+) T cells, the spectrum of signaling responses induced by gp120 through CXCR4 paralleled that induced by the natural ligand stromal cell-derived factor 1/CXCL12. gp120 activated heterotrimeric G proteins and the major G protein-dependent pathways, including calcium mobilization, phosphoinositide-3 kinase, and Erk-1/2 MAPK activation. Interestingly, gp120 caused rapid actin cytoskeleton rearrangements and profuse membrane ruffling, as evidenced by dynamic confocal imaging. This coordinated set of events resulted in a bona fide chemotactic response. Inactivated HIV-1 virions that harbored conformationally intact envelope glycoproteins also caused actin polymerization and chemotaxis, while similar virions devoid of envelope glycoproteins did not. Thus gp120, in monomeric as well as oligomeric, virion-associated form, elicited a complex cellular response that mimicked the effects of a chemokine. HIV-1 has therefore the capacity to dysregulate the vast CD4(+) T cell population that expresses CXCR4. In addition, HIV-1 may exploit its chemotactic properties to retain potential target cells and locally perturb their cytoskeleton, thereby facilitating viral transmission.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15585836     DOI: 10.4049/jimmunol.173.12.7150

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

Review 1.  HIV/AIDS epidemiology, pathogenesis, prevention, and treatment.

Authors:  Viviana Simon; David D Ho; Quarraisha Abdool Karim
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

Review 2.  Early events of HIV-1 infection: can signaling be the next therapeutic target?

Authors:  Kate L Jones; Redmond P Smyth; Cândida F Pereira; Paul U Cameron; Sharon R Lewin; Anthony Jaworowski; Johnson Mak
Journal:  J Neuroimmune Pharmacol       Date:  2011-03-05       Impact factor: 4.147

3.  CCR5/CD4/CXCR4 oligomerization prevents HIV-1 gp120IIIB binding to the cell surface.

Authors:  Laura Martínez-Muñoz; Rubén Barroso; Sunniva Y Dyrhaug; Gemma Navarro; Pilar Lucas; Silvia F Soriano; Beatriz Vega; Coloma Costas; M Ángeles Muñoz-Fernández; César Santiago; José Miguel Rodríguez Frade; Rafael Franco; Mario Mellado
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

Review 4.  Virus cell-to-cell transmission.

Authors:  Walther Mothes; Nathan M Sherer; Jing Jin; Peng Zhong
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

5.  Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4+ T Cells.

Authors:  Nitasha A Kumar; Renee M van der Sluis; Talia Mota; Rachel Pascoe; Vanessa A Evans; Sharon R Lewin; Paul U Cameron
Journal:  J Immunol       Date:  2018-07-20       Impact factor: 5.422

6.  HIV-1 Nef inhibits ruffles, induces filopodia, and modulates migration of infected lymphocytes.

Authors:  Cinzia Nobile; Dominika Rudnicka; Milena Hasan; Nathalie Aulner; Françoise Porrot; Christophe Machu; Olivier Renaud; Marie-Christine Prévost; Claire Hivroz; Olivier Schwartz; Nathalie Sol-Foulon
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

7.  CCL2 increases X4-tropic HIV-1 entry into resting CD4+ T cells.

Authors:  Grant R Campbell; Stephen A Spector
Journal:  J Biol Chem       Date:  2008-09-10       Impact factor: 5.157

8.  Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling.

Authors:  Karl Balabanian; Angélique Levoye; Lysiane Klemm; Bernard Lagane; Olivier Hermine; Julie Harriague; Françoise Baleux; Fernando Arenzana-Seisdedos; Françoise Bachelerie
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

9.  Quantitative phosphoproteomics reveals extensive cellular reprogramming during HIV-1 entry.

Authors:  Jason A Wojcechowskyj; Chuka A Didigu; Jessica Y Lee; Nicholas F Parrish; Rohini Sinha; Beatrice H Hahn; Frederic D Bushman; Shane T Jensen; Steven H Seeholzer; Robert W Doms
Journal:  Cell Host Microbe       Date:  2013-05-15       Impact factor: 21.023

Review 10.  Chemokine coreceptor signaling in HIV-1 infection and pathogenesis.

Authors:  Yuntao Wu; Alyson Yoder
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.